GL1X · GenesisL1 explorer

MolNFT v1 · #172551 · protein

Crystal structure of kpc-2 with hydrolyzed faropenem (ring-open form)

7A61 · Carbapenem-hydrolyzing beta-lactamase kpc: “Crystal structure of kpc-2 with hydrolyzed faropenem (ring-open form)”. X-ray diffraction, 2 ligands (R0B, SO4), 1 pocket (best druggability 0.29). MolNFT v1 #172551 on GenesisL1: 3D…

PDB
7A61
Type
protein
Length
269 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Carbapenem-hydrolyzing beta-lactamase kpc
EC
3.5.2.6
UniProt
Q9F663
Ligands
R0B, SO4
Pockets
1 · best druggability 0.29

Structure

x-ray diffraction · 1 distinct chain · 40% helix, 17% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ACarbapenem-hydrolyzing beta-lactamase kpc (EC 3.5.2.6)protein26940% helix, 17% strandQ9F663

Ligands and binding sites

  • R0B · (2~{R})-2-[(2~{S},3~{R})-1,3-bis(oxidanyl)-1-oxidanylidene-butan-2-yl]-5-butyl-2,3-dihydro-1,3-thiazole-4-carboxylic acid · ligand · chains A
  • SO4 · Sulfate ion · ion · 4 copies · chains A
  • GOL · Glycerol · additive · 2 copies · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

1 pocket found on a 1 Å grid, 0 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
1610.290.7517R0B

Modifications

Observed in the structure: 1 covalent, 1 disulfide (covalent ligand, disulfide).

Compared structures

  • 7A61 · Crystal structure of KPC-2 with hydrolyzed faropenem (ring-open form) · the same entry in another collection · chain A against A, TM-score 1.00
  • Q9F663 · AlphaFold monomer V2.0 prediction for carbapenem-hydrolyzing beta- lactamase kpc (Q9F663) · a predicted model of the same protein · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.